| ID | Name | CAS | Properties |
Tfus (K) |
| 76-676-8 |
3«alpha»-Hydroxy-5«beta»-pregnan-20-one-methyloxime, trimethylsilyl
|
55557-04-5 |
3 | 380.14 |
| 76-978-3 |
2-Amino-3-[(trimethylsilyl)oxy]-2-([(trimethylsilyl)oxy]methyl)propan-1-ol
|
|
3 | 343.46 |
| 81-566-4 |
Silane, [[(3«beta»,22E)-ergosta-7,22-dien-3-yl]oxy]trimethyl-
|
55527-93-0 |
3 | 392.89 |
| 82-753-5 |
1-Phenyl-3-cyclopentadienyl 1,1,3,3-tetramethyl disiloxane
|
|
3 | 238.78 |
| 83-997-4 |
10-{3-[1-[2-(2-Hydroxyethoxy)ethyl]-4-piperazinyl]propyl}-2-trifluoromethyl-phenothiazine, dihydrochloride
|
|
3 | 464.65 |
| 86-180-7 |
24-Ethyl-4-cholesten-3-one, oxime, TMS # 1
|
|
3 | 366.94 |
| 87-324-6 |
Phenothiazine,10-[2-(1-methyl-4-piperazinyl)ethyl]-2-trifluoromethyl-, dihydrochloride
|
|
3 | 498.40 |
| 88-416-3 |
Silane, (ergosta-5,7,22-trien-3«beta»-yloxy)trimethyl-
|
2625-45-8 |
3 | 387.10 |
| 91-411-4 |
5«alpha»-Pregnane-3«alpha»,21-diol-20-one, O,O'-bis(trimethylsilyl)
|
56210-99-2 |
3 | 393.94 |
| 91-412-3 |
5«beta»-Pregnane-3«alpha»,17«alpha»-diol-20-one-di-TMS
|
|
3 | 391.30 |
| 91-413-2 |
5«beta»-Pregnane-3«alpha»,6«alpha»-diol-20-one-di-tms
|
33287-43-3 |
3 | 391.37 |
| 94-123-1 |
1H-Pyrrole-2,5-dione, 1-[4-(dimethylamino)-3,5-dinitrophenyl]-
|
3475-74-9 |
3 | 468.91 |
| 94-702-8 |
24-Ethyl-4-cholesten-3-one, oxime, TMS # 2
|
|
3 | 365.13 |
| 94-724-4 |
24-Ethyl-5-«beta»-cholestan-3-one, oxime, TMS # 1
|
|
3 | 362.16 |
| 94-725-3 |
24-Ethyl-5-«beta»-cholestan-3-one, oxime, TMS # 2
|
|
3 | 362.16 |
| 95-605-5 |
4-[3-(2-Trifluoromethyl-10-phenothiazinyl)propyl]-1-piperazineethanol, acetate, dihydrochloride
|
|
3 | 481.09 |
| 97-084-2 |
Imidazo[4,5-d]imidazole-2,5-(1H,3H)dione, tetrahydro-1,3,4,6-tetramethyl-
|
10095-06-4 |
3 | 501.00 |
| 97-228-2 |
3«beta»,7«alpha»-dihydroxy-5-chol-24-oate, TMS
|
|
3 | 364.33 |
| 97-309-2 |
19-Nor-17«alpha»-pregn-4-en-3-one, 17-(trimethylsiloxy)-
|
6689-89-0 |
3 | 382.81 |
| 102-258-2 |
1-([1,1'-biphenyl]-4-yl(phenyl)methyl)-1H-imidazole
|
|
3 | [415.15; 423.00] |
| 103-667-7 |
2-(propan-2-ylideneamino)oxyethyl 2-[4-(6-chloroquinoxalin-2-yl)oxyphenoxy]propanoate
|
111479-05-1 |
3 | 339.45 |
| 108-708-6 |
methyl 2-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-methylcarbamoyl]sulfamoyl]benzoate
|
101200-48-0 |
3 | 414.15 |
| 109-054-1 |
2-[[4-chloro-6-(cyclopropylamino)-1,3,5-triazin-2-yl]amino]-2-methylpropanenitrile
|
|
3 | 417.39 |
| 109-974-0 |
[3-chloro-4-(diethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate
|
13171-21-6 |
3 | 228.15 |
| 111-199-8 |
[7-(2-methylbut-2-enoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoate
|
303-34-4 |
3 | 368.15 |
| 113-309-3 |
2-Naphthaleneacetic acid, 6-methoxy-«alpha»-methyl-, trimethylsilyl ester, (+)-
|
|
3 | 349.61 |
| 114-271-4 |
6.alpha.-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, anti
|
|
3 | 403.24 |
| 115-176-9 |
Silane, [[(3«alpha»,5«beta»,20R)-pregnane-3,20-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
65598-77-8 |
3 | 387.54 |
| 115-936-5 |
3.alpha.-hydroxy-pregn-4-en-20-one, MO-TMS
|
|
3 | 382.55 |
| 116-075-0 |
4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-6-(trifluoromethyl)-
|
368-54-7 |
3 | 524.15 |
| 116-555-7 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-PFP
|
|
3 | 392.67 |
| 117-993-0 |
Methyl 5-«alpha»-cholan-3-one-24-oate, oxime, TMS # 2
|
|
3 | 377.89 |
| 118-095-6 |
Methyl 5-«alpha»-cholan-3-one-24-oate, oxime, TMS # 1
|
|
3 | 377.89 |
| 118-132-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-
|
2879-15-4 |
3 | 535.75 |
| 118-995-7 |
1H-Purine-2,6-dione, 3,7-dihydro-8-(hydroxymethyl)-1,3-dimethyl-
|
|
3 | 538.09 |
| 119-138-7 |
5-pregnene-3«beta»,16«alpha»,20«alpha»-triol, MO-TMS
|
|
3 | 383.22 |
| 120-304-0 |
1-Piperazine ethanol, 4-[3-(2-trifluoromethyl-10-phenoxazinyl)propyl]-, dihydrochloride
|
|
3 | 468.30 |
| 121-994-4 |
2,5-Cyclohexadien-1-one, 2,6-dichloro-4-(chloroimino)-
|
101-38-2 |
3 | 339.65 |
| 122-110-3 |
1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 8-chloro-1-phenyl-
|
22316-55-8 |
3 | 492.01 |
| 122-958-3 |
Androst-4-ene-3.alpha.,17.beta.-diol , per-TMS
|
|
3 | 370.88 |
| 123-653-0 |
2,4-Pregnadien-(2,3-d)isoxazol-17.alpha.-ethynyl-17.beta.-ol, TMS
|
|
3 | 417.67 |
| 124-022-9 |
5-«alpha»-Pregnan-3-«beta»,21-diol-20-one, MeTMS
|
|
3 | 393.94 |
| 124-350-5 |
2-Chloro-10-(3'-dimethylaminopropyl)phenothiazine, 5-oxide, hydrochloride, monohydrate
|
|
3 | 487.36 |
| 124-791-6 |
20.alpha.-hydroxy-pregn-4-en-3-one, MO-TMS, anti
|
|
3 | 396.40 |
| 32-891-7 |
Manganese, [5,10,15,20-tetraphenyl-21H,23H-porphinato(2-)-N21,N22,N23,N24]-, (SP-4-1)-
|
31004-82-7 |
2 | 685.65 |
| 43-863-6 |
7.alpha.-hydroxy-3-oxo-4-cholestenoate, O-methyloxime, TMS (2)
|
|
2 | 392.71 |
| 53-895-0 |
Nickel complex of 2,2'-thiobis[4-(1,1,3,3-tetramethylbutyl)phenol]
|
|
2 | 578.48 |
| 58-318-5 |
(2,4-Dichlorophenoxy) acetic acid, 2(2-aminoethoxy)ethanol salt
|
|
2 | 372.27 |
| 63-542-0 |
17«beta»-Hydroxy-4-estren-3-one-methyloxime, trimethylsilyl deriv.
|
124460-92-0 |
2 | 369.27 |
| 70-357-8 |
7.alpha.-hydroxy-3-oxo-4-cholesten-26-oate, O-methyloxime, TMS (1)
|
|
2 | 392.71 |
| 77-768-5 |
1,4-Diazabicyclo[2.2.2]octane, compd. with bh3
|
|
2 | 416.48 |
| 78-171-6 |
9H-purine, 6-(methylthio)-9-beta-d-ribofuranosyl-, 5'-barium phosphate, hydrated
|
|
2 | 402.94 |
| 96-149-1 |
Ethanamine, 2-hydroxy-2-(m-hydroxyphenyl)-n-methyl-, 2-hydroxy-3-phenyl benzoic acid salt
|
|
2 | 500.54 |
| 114-778-2 |
Methyl 5-.beta.-cholan-3-one-24-oate, oxime, TMS # 2
|
|
2 | 374.14 |
| 116-022-8 |
N-(beta-cyclohexyl-beta-hydroxy-beta-phenyl-ethyl)-n'-methylpiperazine methosulfate
|
|
2 | 506.49 |
| 119-361-9 |
1-Phenylcyclopentanecarboxylic acid, 2-diethyl-aminoethyl ester, 1,2-ethanedisulfonate
|
|
2 | 523.56 |
| 119-611-1 |
2-Propanol, 1-tert-butylamino-3-(6-chloro-m-tolyloxy)-, hydrochloride
|
15148-80-8 |
2 | 425.23 |
| 120-915-2 |
Methyl 5-.beta.-cholan-3-one-24-oate, oxime, TMS # 1
|
|
2 | 374.14 |
| 121-057-4 |
2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3, 6,11-trimethyl-, hydrochloride, monohydrate
|
|
2 | 479.70 |
| 48-432-9 |
1-Cyclopentadienyl-3-(p-biphenylyl)-1,1,3,3-tetramethyl disiloxane
|
|
1 | 338.18 |
| 49-716-3 |
1-Amino-4-bromo-2-anthraquinone sulfonic acid, sodium salt
|
|
1 | 495.75 |
| 61-490-0 |
2-Butyl-3-benzofuranyl 4-[(2-diethylamino)ethoxy] 3,5-diiodophenyl ketone, hydrochloride
|
19774-82-4 |
1 | 429.15 |
| 71-061-5 |
1,1'-Bis-[3-(p-biphenylyl)-1,1,3,3-tetramethyl disiloxanyl] ferrocene
|
|
1 | 408.78 |
| 73-402-4 |
1,1'-(5-Phenyl-1,1,3,3,5,5-hexamethyltrisiloxanyl)-ferrocene
|
|
1 | 318.82 |
| 78-020-3 |
1,1'-Bis-[3-(x,x-dichlorophenyl)-1,1,3,3 tetramethyl disiloxanyl] ferrocene
|
|
1 | 365.30 |
| 78-107-7 |
1,1'-Bis(3-phenyl-1,1,3,3-tetramethyl disiloxanyl) ferrocene
|
|
1 | 335.17 |
| 78-191-4 |
9-Methyl-3-oxo-9-azabicyclo[3.3.1]nonan-7-ol, benzilate ester, methobromide
|
119299-34-2 |
1 | 592.59 |
| 94-023-2 |
Metanilic acid, n-(2,4-dinitrophenyl)-6-hydroxy-, sodium salt
|
|
1 | 571.31 |
|
« Previous Results
|